Skip Over Navigation Links
NIH National Institutes of Health, DHHS
NIH Home PageHealth InformationGrants & Funding OpportunitiesNewsScientific ResourcesInstitutes, Centers & OfficesAbout NIH
Building 1
Advanced Search Page

Home > Institutes, Centers & Offices > Office of the Director > Freedom Of Information Act Office

Correspondence and Submissions Relating to CellPro March-In Petition

Correspondence Documents

1. March 3, 1997 Original Petition from CellPro (Request that NIH excercise march-in procedures)
    Exhibits A, B, C, D
2. March 21, 1997 Letter from Dr. Wendy Baldwin to Mr. Ronald R. Peterson (Notification to Johns Hopkins University of CellPro petition)
3. March 24, 1997 Letter from Mr. Robert B. Lanman to Mr. Lloyd Cutler (Acknowledgment of receipt of original petition)
4. April 24, 1997 CellPro Supplement to Original Petition, Letter from Mssr. L Cutler and Birch Bayh to Mr. R. Lanman (Additional comments to request)
    Memorandum
    Video: "Multiple Sclerosis Patient Treated with the CEPRATE System"
(Note: Available from NIH FOIA Office)
    Exhibit Volumes I and II
5. April 24, 1997 Letter from Mr. Frederick G. Savage to Mr. R. Lanman (Confirmation of extension until May 7 to file answer to CellPro petition)
6. April 29, 1997 Letter from Mr. R. Lanman to Mr. L. Cutler (Re: April 24 CellPro letter)
7. May 1, 1997 Note from Ms. Barbara McGarey to Mr. Howard Califano (Re: CellPro's supplemental submission)
8. May 7, 1997 Letter from Mr. Donald R. Ware to Mr. R. Lanman (Re: JHU correction to p. 28 of plaintiff's reply brief)
9. May 7, 1997 Letter from Mr. D. Ware to Dr. W. Baldwin, Response of Johns Hopkins to CellPro's Original Petition (Reasons to deny petition)
    Appendix
  Declarations and Exhibits
10. May 8, 1997 Letter from Mr. Gary D. Wilson to Mr. R. Lanman (Re: Baxter response)
11. May 12, 1997 Letter from Mr. D. Ware to Mr. R. Lanman (Request for 30 day period to respond to CellPro April 24 memorandum)
May 15, 1997 Letter from Dr. W. Baldwin to Mr. D. Ware (Re: extension filing date for Johns Hopkins in response to CellPro supplemental materials)
12. May 15, 1997 Letter from William J. Marsden, Jr. to Judge Roderick R. McKelvie (Re: Plaintiff's proposed modification to injunction)
    Order for Permanent Injunction and Partial Stay of Injunction
13.
May 19, 1997 Letter from Mr. G. Wilson to Dr. W. Baldwin (Counter-response of CellPro to response of Johns Hopkins)
14.
May 19, 1997 Letter from Mr. D. Ware to Mr. R. Lanman, Declaration of Scott D. Rowley, MD, Fred Hutchinson Cancer Research Center (Support from research in clinical trials of Baxter Isolex systems)
    Declaration of Dr. Scott D. Rowley
15. May 20, 1997 Letter from Mr. G. Wilson to Ms. Annette Hamburger (Replacement page 4)
16. May 27, 1997 Letter from Dr. W. Baldwin to Mr. D. Ware (Re: further submissions)
17. May 28, 1997 Declaration of Larry Culver, CEO CellPro (Projected financial performance and resulting viability of CellPro under various litigation outcome scenarios)
18. May 30, 1997 Letter from Mr. G. Wilson to Ms. B. McGarey (Supplement to CellPro counter-response)
    Plaintiff's Reply Brief in Support of Motion for a Permanent Injunction, Order for Permanent Injunction and Partial Stay of Injunction
    Declaration of Dr. Bonnie Mills
    Declaration of Dr. James Vrednenburgh
    Declaration of Dr. Juan Lopez
    Declaration of Dr. Bo Bjorkstrand
    Declaration of Dr. Kenneth Cornetta
    Declaration of Kristen Houser
  Declaration of Dr. Robert A. Preti
  Declaration of Dr. Jerry A. Hausman
    Transcript of proceedings of Delaware federal district court hearings, Hopkins, Baxter and Becton Dickinson v. CellPro, April 30, 1997
19. June 2, 1997 Letter from Mssr. F. Savage and D. Ware to Dr. W. Baldwin (Response to Supplemental filing of CellPro petition)
  Appendix
  Exhibits
20. June 6, 1997 Letter from Mr. G. Wilson to Ms. B. McGarey, and
Letter from Mr. Wilson to Mssr. D. Ware and F. Savage
(Offer of settlement)
21. June 12, 1997 Letter from Mr. D. Ware to Ms. B. McGarey (Notice of letter from Baxter to DHHS)
    Letter from Mr. Vernon R. Loucks to Sec. Donna Shalala (Assurance of Baxter to protect patient care and prevent gaps in treatment)
22. June 13, 1997 Letter from Mr. R. Lanman to Mr. D. Ware (Response to assurance of Baxter to DHHS)
23. June 17, 1997 Letter from Mr. D. Ware to Ms. B. McGarey (Response to declaration of CellPro CEO Mr. L. Culver dated May 28, 1997)
    Supplemental Declaration of Dr. Jerry A. Hausman
    Exhibits A-C:
      Exhibit A: Hambrect & Quist Spot, Report March 13, 1997
      Exhibit B: CellPro Press Release, May 14, 1997
      Exhibit C: Letter from Mr. D. Ware to Mr. Coe E. Bloomberg, June 10, 1997
24. June 20, 1997 Letter from Mr. G. Wilson to Ms. B. McGarey (Protest to acceptance of further filings by CellPro, and request for time extension in the alternative)
    Letter from Mr. D. Ware to Mr. G. Wilson dated June 20, Rejection of licensing proposal by CellPro
25. June 23, 1997 Letter from Mr. G. Wilson to Ms. B. McGarey (Response to letter of Mr. Ware, dated June 20)
26. June 24, 1997 Letter from Mr. G. Wilson to Ms. B. McGarey (Submissions to district court)
    Letter from Mr. W. Marsden to Judge R. McKelvie, dated May 15, 1997 & [Proposed] Order for Permanent Injunction and Partial Stay of Injunction, May 15, 1997
    Letter from Mr. D. Ware to Judge R. McKelvie, dated May 28, 1997, & Declaration of Dr. Scott D. Rowley
    Letter from Mr. Gerard M. O'Rourke to Judge R. McKelvie, dated June 5, 1997 & following submissions to the district court:
      Supplemental Declaration of Dr. Monica S. Krieger
      Declaration of Mr. James M. Folson
      Supplemental Declaration of Mr. Edward Kenney
    Letter from Mr. D. Ware to Judge R. McKelvie, dated June 13, 1997 (Response to letter of Mr. G. O'Rourke of June 5)
      Supplemental Declaration of Dr. J. Hausman
    Letter from Mr. Jerrold B. Reilly to Judge R. McKelvie, dated June 16, 1997
    Declaration of Mr. David F. Weeda
27. June 24, 1997 Letter from Mr. R. Lanman to Mr. D. Ware (Response to letter of Mr. Ware, dated June 20)
28. June 26, 1997 Letter from Mr. D. Ware to Ms. B. McGarey (Response to letter of Mr. Wilson, dated June 23)
    Letter from Mr. D. Ware to Judge McKelvie, dated June 25
29. July 2, 1997 Letter from Mr. D Ware to Mr. R. Lanman (Response to letter of Mr. Lanman, dated June 13)
30. July 2, 1997 Letter from Mr. G. Wilson to Ms. B. McGarey
    Response of CellPro to Submissions of Johns Hopkins University and Supplement to Original Petition of CellPro
    Exhibits
31. July 3, 1997 Letter from Mr. Robert D. Murdock to Dr. Myles P. Cunningham
    Testimony of Physicians
    Media Packet
32. July 7, 1997 Letter from Mr. G. Wilson to Ms. A. Hamburger (Correction to error in July 2 response)
33. July 15, 1997 Letter from Mr. D. Ware to Mr. G. Wilson (Re: CellPro July 2 submission)
34. July 18, 1997 Letter from Mr. G. Wilson to Mr. D. Ware (Response to July 15 letter)
35. July 22, 1997 Letter from Sec. D. Shalala to Mr. V. R. Loucks
    Enclosure: Letter from Mr. R. Lanman to Mr. D. Ware (Response to assurance of Baxter to DHHS)
    Letter from Mr. V. R. Loucks to Sec. D. Shalala (July 12)
36. July 24, 1997 Final Judgment Decision in case of Johns Hopkins University, et. al v. CellPro, United States District Court for the District of Delaware (1997)
    Opinion
    Order for Permanent Injunction and Partial Stay of Injunction
    Memorandum Opinion
37. July 29, 1997 Letter from Mr. D. Ware to Ms. B. McGarey (Re: July 2 CellPro filing and July 24 court rulings)
    Appendix
    Exhibits
38. July 30, 1997 Letter from Mr. D. Ware to Ms. B. McGarey (Re: July 28, 1997, issue of BioCentury)
39. August 1, 1997 National Institutes of Health, Office of the Director DETERMINATION In the Case of PETITION OF CELLPRO, INC. Signed by Harold Varmus, M.D., Director, NIH
    Transcript of FDA Biologic Response Modifiers Advisory Committee (dated Feb. 28, 1996)
Note: this is a 12.8 MB compressed file. Click on the title for an automatic download. You will be prompted to save it to disk.
    Letter from Dr. Jay Siegel to Dr. M. Krieger
    Medical Articles
      High-dose chemotherapy for the treatment of breast and ovarian cancer
      Transplantation of the CD34+ hematopietic progenitor cells
      Mobilization and selection of CD34-positive hematopietc progenitors
     

High-dose chemotherapy with stem-cell rescue for the treatment of breast cancer

      High-dose chemotherapy with an autologous stem cell support in advanced ovarian cancer
      Autologous stem cell transplantation for solid tumors in children
      High-dose chemotherapy with autologous stem cell rescue for breast cancer: yesterday, today, and tomorrow
      High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission
      A new 'two step' procedure for 4.5 log depletion of T and B cells in allogenic transplantation and of neoplastic cells in autologous transplantation

Third-Party Correspondence Documents
These documents are available from the NIH FOIA Office.

 

This page was last reviewed on July 20, 2004 .

[ Q&A About NIH | Career Opportunities | Visitor Information | FOIA ]
[ Site Map | Employee Information | Información en español | Search ]

[ Contact Us | Privacy Notice | Disclaimers | Accessibility ]

N I H logo - link to the National Institutes of Health

National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892

    H H S logo - link to U. S. Department of Health and Human Services

Department of Health
and Human Services